| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/21/2014 | CN102573788B 含有重组人白细胞介素-1的口腔护理组合物 Containing recombinant human interleukin-1 oral care compositions |
| 05/21/2014 | CN102559672B 一种重组海参溶菌酶n端多肽、其制备方法和应用 A recombinant lysozyme n-terminal peptide of sea cucumber, its preparation method and application |
| 05/21/2014 | CN102526701B 奶牛性别干扰制剂 Cows gender interference preparations |
| 05/21/2014 | CN102441157B 蛙皮素／胃泌素释放肽拮抗剂用于治疗急性肺损伤的用途 Uses bombesin / gastrin releasing peptide antagonist for the treatment of acute lung injury |
| 05/21/2014 | CN102370969B 一种治疗仔猪蓝耳病的复方中药组合物及其制备方法 A method of treating piglets PRRS compound Chinese medicine composition and its preparation method |
| 05/21/2014 | CN102294016B 治疗血管相关疾病的包含肽的药物组合物 Treating vascular-related diseases of pharmaceutical compositions comprising a peptide |
| 05/21/2014 | CN102112147B Xbp1、cd138、和cs1肽 Xbp1, cd138, and cs1 peptide |
| 05/21/2014 | CN101766808B 系列镇痛活性肽dkk及其类似物的获得方法和应用 Series of methods and applications to obtain analgesic peptides and their analogues dkk |
| 05/21/2014 | CN101675992B β-淀粉样蛋白-类似物-T-细胞表位疫苗 β- amyloid - like -T- cell epitope vaccine |
| 05/21/2014 | CN101343624B 一种重组人生长激素基因的杆状病毒及其制备方法与应用 Baculovirus and its preparation method and application of a recombinant human growth hormone gene |
| 05/20/2014 | US8729248 Sperm-specific cation channel, CATSPER2, and uses therefor |
| 05/20/2014 | US8729244 Method for purifying factor B |
| 05/20/2014 | US8729238 Method of producing nano- and microcapsules of spider silk protein |
| 05/20/2014 | US8729229 Processes for preparing a polypeptide |
| 05/20/2014 | US8729228 Method of producing a modified (poly) peptide |
| 05/20/2014 | US8729226 Cancer therapy method |
| 05/20/2014 | US8729225 Glycogen synthase kinase heteropolyligand polypeptide |
| 05/20/2014 | US8729224 Melanocortin receptor-specific peptides for treatment of female sexual dysfunction |
| 05/20/2014 | US8729099 Pharmaceutically active piperidine derivatives |
| 05/20/2014 | US8729039 Use of inhibitory oligonucleotides to treat autoimmune disease |
| 05/20/2014 | US8729037 Method and medicament for inhibiting the expression of a given gene |
| 05/20/2014 | US8729032 Self-assembling peptide and peptide gel with high strength |
| 05/20/2014 | US8729031 Compounds |
| 05/20/2014 | US8729030 Peptides that bind to the erythropoietin receptor |
| 05/20/2014 | US8729029 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
| 05/20/2014 | US8729028 Noggin-derived peptide and use thereof |
| 05/20/2014 | US8729027 Therapeutic agent for fibromyalgia containing etanercept |
| 05/20/2014 | US8729026 Method for inhibiting autophagy of motor neurons |
| 05/20/2014 | US8729025 Methods for altering MRNA splicing and treating familial dysautonomia by administering kinetin, benzyladenine, and tocotrienols |
| 05/20/2014 | US8729024 Targeted delivery of pharmaceutical compounds |
| 05/20/2014 | US8729023 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 05/20/2014 | US8729022 Stabilised solid compositions of factor VII polypeptides |
| 05/20/2014 | US8729021 PTD-UQCRB fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same |
| 05/20/2014 | US8729020 Methods for the treatment of aortic fibrosis with VIP fragments |
| 05/20/2014 | US8729019 Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents |
| 05/20/2014 | US8729018 Therapeutic agents comprising elastic peptides |
| 05/20/2014 | US8729017 Glucagon/GLP-1 receptor co-agonists |
| 05/20/2014 | US8729016 Oral insulin therapies and protocol |
| 05/20/2014 | US8729015 Solid lipid microcapsules containing growth hormone inner core microparticles |
| 05/20/2014 | US8729014 Specific HCV NS3 protease inhibitors |
| 05/20/2014 | US8729011 Amide based glucagon superfamily peptide prodrugs |
| 05/20/2014 | US8729010 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 05/20/2014 | US8729009 Lysine compounds and their use in site- and chemoselective modification of peptides and proteins |
| 05/20/2014 | US8728813 Methods of expanding and redifferentiating islet beta cells |
| 05/20/2014 | US8728797 Yeast membrane protein expression system and its application in drug screening |
| 05/20/2014 | US8728757 Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1) |
| 05/20/2014 | US8728754 Use of proteins isolated from Pseudomonas to control molluscs |
| 05/20/2014 | US8728747 Alteration of cell membrane for new functions |
| 05/20/2014 | US8728536 Chemotherapeutic composition using nanocrystalline calcium phosphate paste |
| 05/20/2014 | US8728523 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
| 05/20/2014 | US8728512 Treatment and composition for wound healing |
| 05/20/2014 | US8728510 Biocompatible carrier containing a bioadhesive material |
| 05/20/2014 | US8728509 Implant depots to deliver growth factors to treat osteoporotic bone |
| 05/20/2014 | US8728496 Functionalized RGD peptidomimetics and their manufacture, and implant having a coating containing such functionalized RGD peptidomimetics |
| 05/20/2014 | US8728491 Transcutaneous delivery of therapeutic agents |
| 05/20/2014 | US8728485 Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome |
| 05/20/2014 | US8728483 Multivalent fibronectin based scaffold domain proteins |
| 05/20/2014 | US8728480 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof |
| 05/20/2014 | US8728476 Compositions and methods to enhance the immune system |
| 05/20/2014 | US8728475 Methods for treating inflammatory bowel disease |
| 05/20/2014 | US8728469 Method of treating rheumatoid arthritis using anti-IL-20 antibodies |
| 05/20/2014 | US8728467 Methods comprising serratia peptidase for inhibition of osteomyelitis |
| 05/20/2014 | US8728465 Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors |
| 05/20/2014 | US8728456 Programming of cells for tolerogenic therapies |
| 05/20/2014 | CA2809195C Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 05/20/2014 | CA2768810C Skin external-preparation composition |
| 05/20/2014 | CA2723031C Polypeptides having neutrophil stimulating activity |
| 05/20/2014 | CA2716893C Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease |
| 05/20/2014 | CA2657819C Whole blood-derived coagulum device for treating bone defects |
| 05/20/2014 | CA2544853C Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases, and organ transplant rejection |
| 05/20/2014 | CA2532679C Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment |
| 05/20/2014 | CA2519023C Facially amphiphilic polymers and oligomers and uses thereof |
| 05/20/2014 | CA2471504C Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 05/20/2014 | CA2471192C Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 05/20/2014 | CA2469984C Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 05/20/2014 | CA2448567C Modulators of nucleic acid ligands |
| 05/20/2014 | CA2343698C Repair of larynx, trachea, and other fibrocartilaginous tissues |
| 05/15/2014 | WO2014075082A1 Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis |
| 05/15/2014 | WO2014075079A1 Peptidic structures incorporating an amino acid metal complex and applications in magnetic resonance imaging |
| 05/15/2014 | WO2014074997A1 Enzymes for inhibiting growth of biofilms and degrading same |
| 05/15/2014 | WO2014074952A1 Methods and compositions for localized delivery of agents to hiv-infected cells and tissues |
| 05/15/2014 | WO2014074846A1 Methods for the treatment of bone loss |
| 05/15/2014 | WO2014074806A1 Improved reattachment of detached cartilage to subchondral bone |
| 05/15/2014 | WO2014074789A1 Hydrogelators comprising d-amino acids |
| 05/15/2014 | WO2014074114A1 Drying methods for tuning microparticle properties |
| 05/15/2014 | WO2014073919A1 Composition for preventing, treating or reducing alopecia |
| 05/15/2014 | WO2014073845A1 A composition for treating diabetes or diabesity comprising oxyntomodulin analog |
| 05/15/2014 | WO2014073842A1 Liquid formulation of protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment |
| 05/15/2014 | WO2014073529A1 MEDICINE COMPRISING MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL ASSOCIATED WITH ALLERGIC DISEASE, CD300a GENE KNOCK-OUT MOUSE, AND USE OF MODULATOR OF ACTIVITY OF CD300a-EXPRESSING CELL |
| 05/15/2014 | WO2014072958A1 Peptides |
| 05/15/2014 | WO2014072524A1 Lipopetides for use in treating liver diseases and cardiovascular diseases |
| 05/15/2014 | WO2014072481A1 Albumin variants |
| 05/15/2014 | WO2014072446A1 Method for inducing il-2-free proliferation of gamma delta t cells |
| 05/15/2014 | WO2014072330A1 Glucose responsive hydrogel comprising pba-grafted hyaluronic acid (ha) |
| 05/15/2014 | WO2014072235A1 Collagen hydrolyzate and use thereof |
| 05/15/2014 | WO2014071894A1 POLYPEPTIDES DERIVED FROM TGFβ AND USES THEREOF |
| 05/15/2014 | WO2014071892A1 Lamin a, an activator of longevity/anti-aging sirt1 protein |
| 05/15/2014 | WO2014071743A1 Composition containing antifungal drug and lactate buffer |
| 05/15/2014 | WO2014071712A1 Medicinal composition for treating liver injury, and method thereof |
| 05/15/2014 | WO2014071670A1 Use of human sdr5 protein or sdr5-fc antibody fusion protein as medicine for treating myocardial infarction |